期刊文献+

2型糖尿病周围神经病变的危险因素分析 被引量:12

Risk factors analysis of diabetic peripheral neuropathy in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨2型糖尿病周围神经病变(DPN)相关危险因素。方法选取2014年1月至2015年12月在武汉市中心医院住院的2型糖尿病患者427例,分为DPN组(141例)和无DPN组(286例),比较两组各项临床指标,并进一步分析DPN发生的危险因素。结果 DPN组(141例)和无DPN组患者年龄[(61.45±9.39)岁vs(58.07±10.41)岁]、糖尿病病程[(8.64±5.79)年vs(6.93±5.63)年]、糖化血红蛋白(Hb A1c)[(8.67±2.04)%vs(7.91±1.84)%]及空腹血糖水平[(9.84±3.97)mmol/L vs(8.67±3.21)mmol/L]、吸烟率[43例(30.5%)vs 45例(15.7%)]、糖尿病性视网膜病变(DR)的发生率[51例(36.2%)vs 64例(22.4%)]比较,差异均有统计学意义(P<0.05)。多元Logistic回归分析显示年龄、Hb A1c、吸烟、合并DR为DPN发生的独立危险因素(P<0.05)。结论年龄、Hb A1c、吸烟以及合并DR为导致DPN的主要危险因素。 Objective To investigate the risk factors of diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes (T2DM). Methods A total of 427 patients diagnosed with T2DM in the Central Hospital of Wuhan from January 2014 to December 2015 were enrolled and divided into the DPN group (n=141) and the non-DPN group (286). The clinical characters were compared between two groups, and the risk factors of DPN were further analyzed. Results The age, duration of diabetes, glycosylated hemoglobin (HbA1c) level, fasting blood glucose level, smoking rate, incidence of diabetic retinopathy (DR) in the DPN group were respectively (61.45 ± 9.39) years, (8.64 ± 5.79) years, (8.67 ± 2.04)%, (9.84±3.97) mmol/L, 43 (30.5%), 51 (36.2%), which were significantly higher than corresponding (58.07±10.41) years, (6.93 ± 5.63) years, (7.91 ± 1.84)%, (8.67 ± 3.21) mmol/L, 45 (15.7%), 64 (22.4%) in the non-DPN group (P〈0.05). Multivariate logistic regression analysis revealed that age, HbA1c, smoking and DR were independent risk factors for pre-dicting DPN in T2DM patients (P〈0.05). Conclusion Age, HbA1c, smoking and DR were the major risk factors of DPN.
出处 《海南医学》 CAS 2017年第20期3379-3381,共3页 Hainan Medical Journal
基金 湖北省自然科学基金(编号:2010CDB09001)
关键词 2型糖尿病 糖尿病周围神经病变 危险因素 Type 2 diabetes (T2DM) Diabetic peripheral neuropathy (DPN) Risk factors
  • 相关文献

参考文献3

二级参考文献69

  • 1贾伟平,沈琴,包玉倩,陆俊茜,李鸣,项坤三.糖尿病周围神经病变的检测方法及其诊断价值的评估[J].中华医学杂志,2006,86(38):2707-2710. 被引量:88
  • 2汤正义.糖尿病周围神经病变客观检查方法的应用和研究现状[J].内科理论与实践,2007,2(3):157-159. 被引量:12
  • 3全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-678.
  • 4中国2型糖尿病防治指南,2007年版.
  • 5American Diabetes Association.Clinical Practice Recommendations.Diabetes Care,2009,31,S12-S54.
  • 6Said G.Diabetic neuropathy--a review.Nat Clin Pract Neurol.2007,3:331-340.
  • 7Sima AA.New insights into the metabolic and molecular basis for diabetic neuropathy.Cell Mol Life Sci,2003,60:1-20.
  • 8Ziegler D,Siekierka KE,Meyer B,et al.Validation of a novel screening device(NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy.Diabetes Care,2005,28:1169-1174.
  • 9Bouhon AJ,Vinik AI,Arezzo JC,et al.Diabetic neuropathies:a statement by the American Diabetes Association.Diabetes Care,2005,8:956-962.
  • 10Zin CS,Nissen LM,Smith MT,et al.An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.CNS Drugs,2008,22:417-442.

共引文献706

同被引文献111

引证文献12

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部